Ra Capital Management, L.P. Imara Inc. (IMRA) insider trading activity

RA CAPITAL MANAGEMENT, L.P. Transaction History

Date	Transaction	Value	Shares Traded
Feb 23 2023	BUY Grant, award, or other acquisition	-	1,152,460
Jan 03 2023	BUY Open market or private purchase	$2,517,188 $4.0 p/Share	629,297
Dec 09 2022	BUY Open market or private purchase	$75,845 $3.93 p/Share	19,299
Dec 08 2022	BUY Open market or private purchase	$39,750 $3.75 p/Share	10,600
Oct 24 2022	BUY Open market or private purchase	$103,459 $3.91 p/Share	26,460
Oct 21 2022	BUY Open market or private purchase	$188,552 $3.92 p/Share	48,100
Oct 20 2022	BUY Open market or private purchase	$44,801 $3.95 p/Share	11,342

Oct 19 2022	BUY Open market or private purchase	$489,074 $3.89 p/Share	125,726
Oct 18 2022	BUY Open market or private purchase	$882,844 $3.76 p/Share	234,799
Oct 17 2022	BUY Open market or private purchase	$489,458 $3.36 p/Share	145,672
Mar 16 2020	BUY Open market or private purchase	$10,000,000 $16.0 p/Share	625,000
Mar 16 2020	BUY Conversion of derivative security	-	829,348

Also insider at

KALV

KalVista Pharmaceuticals, Inc. Healthcare

Director

WVE

Wave Life Sciences Ltd. Healthcare

Director

DRNA

Dicerna Pharmaceuticals Inc

> 10% Shareholder

RARX

Ra Pharmaceuticals, Inc.

Director

EIDX

Eidos Therapeutics, Inc.

Director

ARVN

ARVINAS, INC. Healthcare

KALA

Kala Pharmaceuticals, Inc. Healthcare

> 10% Shareholder

THOR

Synthorx, Inc.

> 10% Shareholder

SCPH

scPharmaceuticals Inc. Healthcare

> 10% Shareholder

STSA

Satsuma Pharmaceuticals, Inc. Healthcare

ETNB

89bio, Inc. Healthcare

PHAT

Phathom Pharmaceuticals, Inc. Healthcare

> 10% Shareholder

VSTM

Verastem, Inc. Healthcare

> 10% Shareholder

FMTX

Forma Therapeutics Holdings, Inc. Healthcare

Director

RYTM

RHYTHM PHARMACEUTICALS, INC. Healthcare

AKUS

Akouos, Inc. Healthcare

> 10% Shareholder

NKTX

Nkarta, Inc. Healthcare

PAND

Pandion Therapeutics, Inc.

> 10% Shareholder

INZY

Inozyme Pharma, Inc. Healthcare

> 10% Shareholder

ITOS

iTeos Therapeutics, Inc. Healthcare

INBX

Inhibrx, Inc. Healthcare

> 10% Shareholder

TGTX

TG THERAPEUTICS, INC. Healthcare

> 10% Shareholder

DYN

Dyne Therapeutics, Inc. Healthcare

> 10% Shareholder

PMVP

PMV Pharmaceuticals, Inc. Healthcare

> 10% Shareholder

PCVX

Vaxcyte, Inc. Healthcare

> 10% Shareholder

ORTX

Orchard Therapeutics plc Healthcare

Director

ITRM

Iterum Therapeutics plc Healthcare

> 10% Shareholder

VOR

Vor Biopharma Inc. Healthcare

SLDB

Solid Biosciences Inc. Healthcare

Director

HOWL

Werewolf Therapeutics, Inc. Healthcare

JANX

Janux Therapeutics, Inc. Healthcare

PNT

POINT Biopharma Global Inc. Healthcare

Director

AVTE

Aerovate Therapeutics, Inc. Healthcare

ABOS

Acumen Pharmaceuticals, Inc. Healthcare

CTKB

Cytek Biosciences, Inc. Healthcare

Director

ICVX

Icosavax, Inc. Healthcare

ELYM

Eliem Therapeutics, Inc. Healthcare

TYRA

Tyra Biosciences, Inc. Healthcare

DICE

DICE Therapeutics, Inc. Healthcare

ANTX

AN2 Therapeutics, Inc. Healthcare

> 10% Shareholder

PEPG

PepGen Inc. Healthcare

SBTX

Silverback Therapeutics, Inc. Healthcare

ACRV

Acrivon Therapeutics, Inc.

FULC

Fulcrum Therapeutics, Inc. Healthcare

> 10% Shareholder

MLYS

Mineralys Therapeutics, Inc.

BDTX

Black Diamond Therapeutics, Inc. Healthcare

Director

GRPH

Graphite Bio, Inc. Healthcare

BOLD

Boundless Bio, Inc.

CDTX

Cidara Therapeutics, Inc. Healthcare

RCM